Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Business Bank begins direct startup investment

3 min read
16:30UTC

The British Business Bank can now lead venture rounds and invest up to £60m per company, backed by a £6.6bn mandate. It is the first time the state bank has competed directly with private VCs.

TechnologyDeveloping
Key takeaway

The British Business Bank moves from backing funds to backing companies, up to £60m per deal.

HM Treasury gave the British Business Bank (BBB) an additional £6.6bn mandate to deploy by 2030, with a new power to lead venture rounds and invest directly in startups at up to £60m per company from April 2026⁠1. A new £4bn Industrial Strategy Growth Capital Initiative targets eight priority sectors including advanced manufacturing, clean energy, defence, and life sciences. Total BBB financial capacity now stands at £25.6bn.

The BBB has historically operated as a fund-of-funds, distributing capital through intermediary managers rather than picking companies. Direct investment at Series B and C scale places government capital in direct competition and collaboration with VC funds. The £60m single-company cap is large enough for meaningful growth rounds; it signals an intent to anchor later-stage deals rather than seed the earliest companies.

The mandate also tasks the BBB with mobilising pension fund and insurance capital into UK growth companies, a structural gap that has left UK founders dependent on foreign investors for large rounds. The BBB's previous track record (£6.3bn in public funding generating an estimated £43bn in gross value added) will be the benchmark against which this expanded role is measured.

Deep Analysis

In plain English

The British Business Bank (BBB) is a government-owned bank that supports small and growing companies. Until now, it mostly invested indirectly, by putting money into private venture capital funds which then invested in startups. From April 2026, it can now invest directly: write a cheque straight to a company for up to £60m. This is a significant change. The government is now a direct participant in the UK startup investment market, writing its own cheques rather than routing money through private funds. Whether that is good or bad depends on whether government-backed capital crowds out or complements private investors.

Deep Analysis
Root Causes

The BBB direct investment mandate addresses a specific structural gap: UK pension and insurance funds are legally permitted but practically constrained from investing in UK venture capital by liability-matching obligations and illiquidity premiums.

The UK Pension Schemes Act 2021's illiquidity disclosure requirements and the FCA's Solvency UK framework (replacing Solvency II) create cost-of-capital advantages for liquid public equities over illiquid VC positions. The BBB is compensating for a regulatory-induced market failure rather than a genuine absence of investable capital.

The £4bn Industrial Strategy Growth Capital Initiative within the BBB mandate is also a response to the concentration of UK VC in London and the South East. Cambridge, Oxford, and London receive approximately 80% of UK venture investment by value. The regional allocation mandate within the BBB's eight priority sectors is intended to address this geographic distortion.

What could happen next?
  • Opportunity

    UK growth-stage companies in eight priority sectors gain access to a new lead investor capable of writing £60m cheques without US VC involvement.

  • Risk

    BBB direct investment at growth stage may reduce private VC pricing discipline and distort valuations in priority sectors, creating zombie-company risk if government capital sustains companies that the market would otherwise price out.

First Reported In

Update #1 · State capital floods in, seed money drains

HM Treasury· 13 Apr 2026
Read original →
Causes and effects
This Event
Business Bank begins direct startup investment
The UK's state development bank shifts from fund-of-funds to direct competitor and co-investor alongside private venture capital.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.